RIL
CERE

Rothschild Investment LLC’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Rothschild Investment LLC’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$1.02K – 3007
2024
Q2 		$1.02K Buy
25
+20
+400% +$833 ﹤0.01% 1646
2024
Q1 		$211 Buy
+5
New +$210 ﹤0.01% 1724

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Rothschild Investment LLC's CERE Position: Q3 2024 in Review

Rothschild Investment LLC sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 25 shares — an estimated $1.02K sold.

Rothschild Investment LLC first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $1.02K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Rothschild Investment LLC reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Rothschild Investment LLC sold 25 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.02K.
  • Rothschild Investment LLC first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Rothschild Investment LLC's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.02K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Rothschild Investment LLC's 13F filing for Q3 2024, filed 18 Oct 2024.